Table 2 Aids to sexual recovery after post-prostatectomy radiation therapy (currently researched)

From: Counseling patients about sexual health when considering post-prostatectomy radiation treatment

Pharmacological

Physical

Psycho-sexual

Penile rehabilitation options (pretreatment)

Penile rehabilitation (pretreatment)

Education (pretreatment)

Low-dose prostaglandin E intracavernosal injections (5–10 mcg) or transurethral suppositories (125–250 mcg) periodically for 1 month or

Kegel exercises (3 sets of 10) daily

Psychoeducation about the effect of prostate cancer treatment on sexual functioning

Low-dose phosphodiesterase 5 inhibitors (1/2 tab every other day) for 1 month

Physical therapy for pelvic floor rehabilitation

Psychoeducation about the typical emotional responses that men and partners experience in the aftermath of prostate cancer treatment (grief and mourning of old sexuality)

Penile rehabilitation options (posttreatment)

Penile rehabilitation (posttreatment)

Interventions (posttreatment)

Low-dose prostaglandin E intracavernosal injections (5–10 mcg) or transurethral suppositories (125–250 mcg) every other day for 6 months or

Kegel exercises (3 sets of 10) daily

Comprehensive psychosexual assessment for the individual and couple

Low-dose phosphodiesterase 5 inhibitors (1/2 dose every other day) for 6 months

Physical therapy for pelvic floor rehabilitation

Psychoeducation about sexual recovery for the man and for the couple: sexual changes, feelings about them, need for experimentation as a part of developing new sexual relationship

Testosterone replacement

Vacuum erectile devices (thrice a week) for 6 months

Sex therapy when couple has concerns about resuming sexual relationship

 

Self-stimulation/masturbation (daily) for 6 months

Individual psychotherapy when man or partner is having difficulty adapting to new sexuality

Options of aids to erections

Options of aids to erections

Couple therapy when sexual issues are embedded in long-term couple difficulties

Prostaglandin E intracavernosal injections (5–20 mcg) or transurethral suppositories (125–1000 mcg)

Vacuum erectile devices

Support groups

Phosphodiesterase 5 inhibitors

Vasoconstrictive rings

Self-help books on sexuality after cancer treatment